| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/03/2011 | WO2011025883A2 Natural igm antibodies |
| 03/03/2011 | WO2011025814A1 Methods and compositions for treatment of lung injury |
| 03/03/2011 | WO2011025572A1 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 03/03/2011 | WO2011025128A2 Method for treating th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor |
| 03/03/2011 | WO2011024748A1 Modified peptide vaccine derived from influenza m2 |
| 03/03/2011 | WO2011024113A1 Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide |
| 03/03/2011 | WO2011024072A2 Hybrid polypeptides including meningococcal fhbp sequences |
| 03/03/2011 | WO2011024071A1 Adjuvant comprising aluminium, oligonucleotide and polycation |
| 03/03/2011 | WO2011023958A1 Screening methods |
| 03/03/2011 | WO2011023785A1 Targeting tissue factor to activated platelets |
| 03/03/2011 | WO2011023764A1 Means and methods for producing artificial capsular polysaccharides of neisseria meningitidis |
| 03/03/2011 | WO2011023623A1 Velocity factor |
| 03/03/2011 | WO2011023390A1 Antibodies against cdcp1 for the treatment of cancer |
| 03/03/2011 | WO2011023389A1 Humanized anti-cdcp1 antibodies |
| 03/03/2011 | WO2011023250A1 Treatment of neurological or neurodegenerative disorders |
| 03/03/2011 | WO2011023130A1 Anti-vegf monoclonal antibody and pharmaceutical composition comprising said antibody |
| 03/03/2011 | WO2011006915A3 Improved anti-serum albumin binding single variable domains |
| 03/03/2011 | WO2011005377A9 Compositions and methods comprising vegfr-2 and vegfr-3 antagonists for the treatment of metastatic disease |
| 03/03/2011 | WO2010148496A8 Lipidated tumor- associated antigens and immunotherapeutic compositions |
| 03/03/2011 | WO2010148223A3 Anti-vegf antibodies and their uses |
| 03/03/2011 | WO2010141143A3 Engineered avirulent bacteria strains and use in medical treatments |
| 03/03/2011 | WO2010141084A3 Recombinant subunit west nile virus vaccine for protections of human subjects |
| 03/03/2011 | WO2010132622A3 Anticd20-cpg conjugates and methods of treating b cell malignancies |
| 03/03/2011 | WO2010132561A8 New human rotavirus strains and vaccines |
| 03/03/2011 | WO2010126319A3 Lipopeptide with specific affinity to the fc region of an antibody, and antigen-recognizing lipid nanoparticle comprising same |
| 03/03/2011 | WO2010124163A3 Granulocyte-macrophage colony-stimulating factor (gm-csf) neutralizing antibodies |
| 03/03/2011 | WO2010123971A3 Hydrogels for combinatorial delivery of immune-modulating biomolecules |
| 03/03/2011 | WO2010115092A3 Compositions and methods for treating or preventing inflammatory bowel disease and colon cancer |
| 03/03/2011 | WO2010111018A8 Antibody drug conjugates (adc) that bind to 24p4c12 proteins |
| 03/03/2011 | WO2010104748A3 Antigen presenting cell targeted anti-viral vaccines |
| 03/03/2011 | WO2010098613A9 Tm7sf3 composition for diagnosing liver cancer, diagnostic kit containing anti-tm7sf3 antibodies, and pharmaceutical composition for preventing or treating liver cancer |
| 03/03/2011 | WO2010091234A9 Methods of treating vascular lesions |
| 03/03/2011 | WO2010039900A3 Non-human mammals for the production of chimeric antibodies |
| 03/03/2011 | WO2008152447A3 Staphylococcus aureus specific anti-infectives |
| 03/03/2011 | US20110055942 Single domain TDF-related compounds and analogs thereof |
| 03/03/2011 | US20110054442 Cell Membrane Translocation of Regulated Snare Inhibitors, Compositions Therefor, and Methods for Treatment of Disease |
| 03/03/2011 | US20110054347 Devices for Selective Recruitment, Isolation, Activation, and/or Elimination of Various Cell Populations |
| 03/03/2011 | US20110053954 Method of treatment and/or prevention of brain, spinal or nerve injury |
| 03/03/2011 | US20110053828 Use of Urea-Adjuvated Polypeptides for Diagnosis, Prophylaxis and Therapy |
| 03/03/2011 | US20110053260 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 03/03/2011 | US20110053259 Recombinant poxvirus expressing homologous genes inserted into the poxvirus genome |
| 03/03/2011 | US20110053217 Polynucleotides encoding signal peptide-containing molecules |
| 03/03/2011 | US20110053182 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 03/03/2011 | US20110053148 Coccidiosis vaccines |
| 03/03/2011 | US20110052716 Adjuvant Comprising Aluminum, Oligonucleotide and Polycation |
| 03/03/2011 | US20110052678 Method for treating age related macular degeneration |
| 03/03/2011 | US20110052677 Modulation of srpx2-mediated angiogenesis |
| 03/03/2011 | US20110052671 Near infra-red pulsed laser triggered drug release from hollow nanoshell disrupted vesicles and vesosomes |
| 03/03/2011 | US20110052668 Identification and Characterization of a Specific CCK-C Receptor Antibody for Human Pancreatic Cancer and Its Use for Early Detection and Staging of Pancreatic Cancer |
| 03/03/2011 | US20110052667 Compositions and methods for inhibiting angiogenesis and tumorigenesis |
| 03/03/2011 | US20110052642 Peripheral zone tumor cells, methods for their preparation and use |
| 03/03/2011 | US20110052640 Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies |
| 03/03/2011 | US20110052639 Allergen mutants |
| 03/03/2011 | US20110052638 Allergens from aspergillus versicolor, and method of detecting a mold allergy caused by interior rooms |
| 03/03/2011 | US20110052637 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as vaccines |
| 03/03/2011 | US20110052636 Method for treating premature ejaculation with a botulinum neurotoxin |
| 03/03/2011 | US20110052635 Live attenuated salmonella vaccine |
| 03/03/2011 | US20110052634 Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof |
| 03/03/2011 | US20110052633 Multi-phase emulsions based on amphiphilic block copolymers |
| 03/03/2011 | US20110052632 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 03/03/2011 | US20110052631 Induction of proliferation, effector molecule expression, and cytolytic capacity of hiv-specific cd8+ t cells |
| 03/03/2011 | US20110052630 Compositions and Methods Using Herpes Simplex Virus |
| 03/03/2011 | US20110052629 Methods of reducing concomitant infections in pigs with a pcv2 antigen |
| 03/03/2011 | US20110052628 Recombinant Double-Stranded RNA Phage, and Use of the Same |
| 03/03/2011 | US20110052627 Recombinant modified vaccinia virus measles vaccine |
| 03/03/2011 | US20110052626 Leporipoxvirus-derived vaccine vectors |
| 03/03/2011 | US20110052624 Type 5 And Type 8 Capsular Polysaccharides Of Overproducing S. Aureus Strains |
| 03/03/2011 | US20110052621 Pcsk9 vaccine |
| 03/03/2011 | US20110052620 Hybrid polypeptides comprising gbs-80 and spb1 proteins of streptococcus |
| 03/03/2011 | US20110052619 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 03/03/2011 | US20110052618 Influenza hemagglutinin and neuraminidase variants |
| 03/03/2011 | US20110052617 Aav scleroprotein, production and use thereof |
| 03/03/2011 | US20110052616 Biological materials and uses thereof |
| 03/03/2011 | US20110052615 Tumour-specific animal proteins |
| 03/03/2011 | US20110052614 Stat3 epitope peptides |
| 03/03/2011 | US20110052613 Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase |
| 03/03/2011 | US20110052612 Spiropiperidine compound and medicinal use thereof |
| 03/03/2011 | US20110052611 Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease |
| 03/03/2011 | US20110052610 Antibody composition exhibiting cellular cytotoxicty due to glycosylation |
| 03/03/2011 | US20110052609 Magnetic transducers |
| 03/03/2011 | US20110052608 Novel antibodies against prion protein and uses thereof |
| 03/03/2011 | US20110052607 Methods of diagnosing myelodysplastic syndrome (mds) or leukemia using nucleic acids or fragments encoding flt3 kinase |
| 03/03/2011 | US20110052606 Humanized Anti-Human NKG2A Monoclonal Antibody |
| 03/03/2011 | US20110052605 Assay for soluble cd200 |
| 03/03/2011 | US20110052604 Human Anti-OPGL Neutralizing Antibodies as Selective OPGL Pathway Inhibitors |
| 03/03/2011 | US20110052603 method of treatment and agents useful for same |
| 03/03/2011 | US20110052602 Diagnosis and Treatment of Age Related Macular Degeneration |
| 03/03/2011 | US20110052601 Compositions comprising anti-icam-1 antibodies |
| 03/03/2011 | US20110052600 Il-17ra-il-17rb antagonists and uses thereof |
| 03/03/2011 | US20110052599 Facilitation of Oocyte, Zygote and Pre-Implantation Embryo Maturation |
| 03/03/2011 | US20110052598 Method for screening of therapeutic agent for allergic airway inflammation and/or airway hypersensitivity using il-17rb-positive nkt cell |
| 03/03/2011 | US20110052597 Anti-IL-13R Alpha1 Antibodies and Their Uses Thereof |
| 03/03/2011 | US20110052596 Antibodies to il-17a |
| 03/03/2011 | US20110052595 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 03/03/2011 | US20110052594 Agents that dissolve arterial thrombi |
| 03/03/2011 | US20110052593 Breast cancer associated antigen |
| 03/03/2011 | US20110052592 Compositions and Methods for Use for Antibodies Against Sclerostin |
| 03/03/2011 | US20110052591 Variants of Thyroid Stimulating Hormone Beta |
| 03/03/2011 | US20110052590 Neutrokine-alpha antibodies and methods of use thereof |
| 03/03/2011 | US20110052589 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |